Amarin drops 6% in after-hours after announcing capital raiseAmarin after the market close today announced a registered underwritten public offering of its American Depositary Shares. All of the shares in the proposed offering are to be sold by Amarin. The stock is down 6% in after-hours trading, or $1.09, to $18.30. Bloomberg reported that the offering will be for $200M of shares and be priced at a range of $17.85-$18.50. Jefferies and Cantor Fitzgerald are acting as the joint book-running managers for the offering. Amarin intends to use the net proceeds from the offering to support the ongoing commercialization of Vascepa, including seeking regulatory approval to expand the approved label for Vascepa, beginning with submission of a Supplemental New Drug Application to the FDA in early 2019.Read more at: https://thefly.com/landingPage...(Source theFly) * This stock has been on our trading list for a while now. Will continue to look for trades in this name. *Tiger's Take: "This maybe a good buying opportunity on the drop due to an offering". $AMRN, Amarin Corporation plc / H1 Disclosure: I may trade in the ticker symbols mentioned, both long or short. My articles represent my personal opinion and analysis and should not be taken as investment advice. Readers should do their own research before making decisions to buy or sell securities. Trading and investing include risks, including loss of principal. If you liked this article, please click the LIKE (thumbs up) button. Feel free to leave any comments, question, or opinions. Follow us and check back occasionally for additional articles or posts.